A randomized, double blind, placebo controlled, phase 2 study testing the use of combination multi-allergen food desensitization with dupilumab or omalizumab in multi-food allergic individuals

$161,924U19FY2022AINIH

Stanford University, Stanford CA

Investigators

R. Sharon Chinthrajahcontact

Linked publications, trials & patents

Paper 39291253 Paper 39038588 Paper 39003568 Paper 38875768 Paper 38630620 Paper 38262500 Paper 38013157 Paper 37916710 Paper 37684288 Paper 37615338 Paper 37572755 Paper 37479682 Paper 37100276 Paper 37059295 Paper 36872039 Paper 36828082 Paper 36652536 Paper 36466872 Paper 36456584 Paper 36333296 Paper 35660711 Paper 35561839 Paper 35469840 Paper 35434655 Paper 35143054 Paper 35014049 Paper 34981779 Paper 34862792 Paper 34655480 Paper 34533570 Paper 34521836 Paper 34477811 Paper 34153372 Paper 34089927 Paper 33991353 Paper 33782956 Paper 33300157 Paper 33274454 Paper 33224714 Paper 33205028 Paper 33160970 Paper 32835695 Paper 32783912 Paper 32750160 Paper 32434067 Paper 32407549 Paper 32340580 Paper 32323379 Paper 32266046 Paper 32161403 Paper 32139586 Paper 32112426 Paper 32107388 Paper 32060492 Paper 32035606 Paper 31892734 Paper 31857699 Paper 31805311 Paper 31724180 Paper 31678426 Paper 31633026 Paper 31591569 Paper 31522849 Paper 31513908 Paper 31500217 Paper 31440440 Paper 31315057 Paper 31193674 Paper 30932909 Paper 30862852 Paper 30825678 Paper 30776022 Paper 30742126 Paper 30654052 Paper 30538699 Paper 30524424 Paper 30298065 Paper 30193111 Paper 30018331 Paper 29985342 Paper 29709643 Paper 29508712 Paper 29455358 Paper 29431212 Paper 29296108 Paper 29296107 Paper 29248495 Paper 29242014 Paper 29127297 Paper 28889067 Paper 28865877 Paper 28790503 Paper 28780941 Paper 28606590 Paper 28469089 Paper 28385925 Paper 28351786 Trial NCT03679676 Trial NCT03539692 Trial NCT02643862

View original record on NIH RePORTER →